BTAIVSRLMD• 3 Months (Normalized)
BTAI vs RLMD (BioXcel Therapeutics Inc. vs Relmada Therapeutics Inc.)
Showing Closing Date Range from Jun, 13 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.05
-95.6%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
RLMD Performance $4.52
-29.04%
Relmada Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin RLMD LEADS
-66.56%
RLMD outperforming by 66.56%
BTAIRLMD
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI RLMD
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | BTAI Price | BTAI Gain (%) | RLMD Price | RLMD Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $0.05 | -95.60% | $4.52 | -29.04% | -66.56% |
| Sep 10, 2026 | $0.05 | -95.69% | $4.07 | -36.11% | -59.58% |
| Sep 09, 2026 | $0.05 | -95.95% | $4.09 | -35.79% | -60.16% |
| Sep 08, 2026 | $0.04 | -96.29% | $4.25 | -33.28% | -63.01% |
| Sep 04, 2026 | $0.07 | -93.63% | $4.43 | -30.46% | -63.17% |
| Sep 03, 2026 | $0.12 | -89.83% | $4.37 | -31.40% | -58.43% |
| Sep 02, 2026 | $0.11 | -90.78% | $4.54 | -28.73% | -62.05% |
| Sep 01, 2026 | $0.14 | -88.19% | $4.46 | -29.98% | -58.21% |
| Aug 31, 2026 | $0.16 | -85.95% | $4.36 | -31.55% | -54.40% |
| Aug 28, 2026 | $0.18 | -84.40% | $4.33 | -32.03% | -52.37% |
| Aug 27, 2026 | $0.72 | -38.02% | $4.52 | -29.04% | -8.98% |
| Aug 26, 2026 | $0.78 | -32.76% | $4.55 | -28.57% | -4.19% |
| Aug 25, 2026 | $0.74 | -36.03% | $4.59 | -27.94% | -8.09% |
| Aug 24, 2026 | $0.76 | -34.40% | $4.58 | -28.10% | -6.30% |
| Aug 21, 2026 | $0.80 | -30.69% | $4.63 | -27.32% | -3.37% |
Page 1 of 5